Sinopharm
1099.HK
#2834
Rank
โ‚ฌ5.21 B
Marketcap
1,67ย โ‚ฌ
Share price
-1.01%
Change (1 day)
-18.25%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚ฌ73.40 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚ฌ73.40 Billion. In 2025 the company made a revenue of โ‚ฌ73.40 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ71.51 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚ฌ73.40 B2.65%
2024โ‚ฌ71.51 B-5.1%
2023โ‚ฌ75.35 B5.42%
2022โ‚ฌ71.48 B-2.1%
2021โ‚ฌ73.01 B16.85%
2020โ‚ฌ62.48 B14.95%
2019โ‚ฌ54.35 B21.52%
2018โ‚ฌ44.73 B5.93%
2017โ‚ฌ42.22 B27.22%
2016โ‚ฌ33.19 B5.37%
2015โ‚ฌ31.49 B9.14%
2014โ‚ฌ28.85 B17.22%
2013โ‚ฌ24.61 B25.94%
2012โ‚ฌ19.54 B34.61%
2011โ‚ฌ14.52 B55.34%
2010โ‚ฌ9.34 B35.79%
2009โ‚ฌ6.88 B37.56%
2008โ‚ฌ5.00 B31.43%
2007โ‚ฌ3.80 B40.26%
2006โ‚ฌ2.71 B